{
    "2020-08-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Myriad Genetics' (MYGN) Q4 Loss Narrower Than Estimated",
                "features": {
                    "keywords": [
                        "Myriad",
                        "Genetics",
                        "Q4",
                        "Loss",
                        "Narrower",
                        "Estimated"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Accuray (ARAY) Reports Loss in Q4, Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "Accuray",
                        "ARAY",
                        "Reports",
                        "Loss",
                        "Q4",
                        "Revenues",
                        "Miss",
                        "Estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}